-
1
المؤلفون: Dimitrios A Pappas, Kelechi Emeanuru, T. Blachley, Susan Boklage, Jeannie Choi, Gregory St John, Rajeshwari S. Punekar, Toshio Kimura, Stefano Fiore, Carol J. Etzel, Joel M. Kremer
المصدر: Annals of the Rheumatic Diseases
مصطلحات موضوعية: Male, rheumatoid arthritis, DMARDs (biologic), Etanercept, Arthritis, Rheumatoid, chemistry.chemical_compound, Piperidines, Immunology and Allergy, Registries, Certolizumab pegol, Antibodies, Monoclonal, Middle Aged, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Female, Rituximab, medicine.drug, TNF-alpha, Adult, musculoskeletal diseases, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, Abatacept, outcomes research, Tocilizumab, Rheumatology, Internal medicine, medicine, Adalimumab, Humans, Patient Reported Outcome Measures, Propensity Score, Aged, Biological Products, business.industry, Recommendation, medicine.disease, Golimumab, Infliximab, Interleukin 1 Receptor Antagonist Protein, Pyrimidines, chemistry, Certolizumab Pegol, Tumor Necrosis Factor Inhibitors, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6fed49555e547330f49728cc647103Test
http://europepmc.org/articles/PMC7788059Test -
2
المؤلفون: Yuxiang Ma, Ming Zhao, Yan Huang, Xiuyu Cai, Wenqi Jiang, Yixin Zhou, Hongyun Zhao, Chen Chen, Xiaoshi Zhang, Wenfeng Fang, Zuan Lin, Shaodong Hong, Li Zhang, Xuanye Zhang, Rui-Hua Xu, Yunpeng Yang, Bei Zhang
المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, HBsAg, medicine.medical_treatment, Programmed Cell Death 1 Receptor, medicine.disease_cause, Gastroenterology, B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, Risk Factors, Neoplasms, PD-1, Immunology and Allergy, Cancer, biology, Checkpoint, virus diseases, Middle Aged, Reactivation, Hepatitis B, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, virology, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Immunotherapy, Safety, Antibody, liver disease, Research Article, Adult, PD-L1, medicine.medical_specialty, Hepatitis B virus, Immunology, Antiviral Agents, lcsh:RC254-282, Young Adult, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Retrospective Studies, Pharmacology, Hepatitis, Chemotherapy, Hepatitis B Surface Antigens, business.industry, medicine.disease, digestive system diseases, 030104 developmental biology, Alanine transaminase, Commentary, biology.protein, Virus Activation, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea49583d5b5c254a92def2d9371d965Test
http://link.springer.com/article/10.1186/s40425-019-0808-5Test -
3
المؤلفون: Philip Beale, Yoland Antill, Sonia Yip, Amanda B. Spurdle, Kristy P. Robledo, Catherine Shannon, Elizabeth H Barnes, Deborah Smith, Tarek Meniawy, Peey-Sei Kok, Michelle M. Cummins, Michael Friedlander, Jermaine Coward, Sally Baron-Hay, Linda Mileshkin, Martin R. Stockler, John Andrews, Geraldine Goss, Janine M. Lombard, Yeh Chen Lee
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Durvalumab, medicine.medical_treatment, Immunology, Phases of clinical research, DNA Mismatch Repair, programmed cell death 1 receptor, Drug Administration Schedule, Antineoplastic Agents, Immunological, Internal medicine, Clinical endpoint, Immunology and Allergy, Medicine, Humans, Adverse effect, RC254-282, Aged, Pharmacology, Clinical/Translational Cancer Immunotherapy, Chemotherapy, clinical trials, business.industry, Endometrial cancer, phase II as topic, Antibodies, Monoclonal, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, Survival Analysis, Endometrial Neoplasms, Clinical trial, Treatment Outcome, Cohort, Molecular Medicine, Female, immunotherapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a56b01ba8ce00e7efa33f5ce36561b0Test
https://jitc.bmj.com/content/9/6/e002255.fullTest -
4
المؤلفون: Peixin Chen, Chunyan Wu, Minlin Jiang, Yi Xu, Liping Zhang, Jun Zhu, Chenglong Sun, Yayi He, Jia Yu, Caicun Zhou, Shengyu Wu, Hao Wang, Qiyu Fang, Hui Sun, Wencheng Zhao, Zixuan Zheng
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: lymphocytes, Male, Oncology, Cancer Research, Lung Neoplasms, Time Factors, Machine Learning, Risk Factors, Immunotherapy Biomarkers, Tumor Microenvironment, Immunology and Allergy, RC254-282, Aged, 80 and over, Framingham Risk Score, biology, FOXP3, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Forkhead Transcription Factors, Middle Aged, Immunohistochemistry, Treatment Outcome, Molecular Medicine, Female, Adult, tumor, medicine.medical_specialty, CD3, Immunology, chemical and pharmacologic phenomena, Risk Assessment, programmed cell death 1 receptor, Decision Support Techniques, Immune system, Predictive Value of Tests, Internal medicine, Biomarkers, Tumor, medicine, Humans, Lung cancer, Aged, Neoplasm Staging, Retrospective Studies, Pharmacology, Tumor microenvironment, business.industry, biomarkers, tumor-infiltrating, medicine.disease, Small Cell Lung Carcinoma, Nomograms, biology.protein, Neoplasm Recurrence, Local, business, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a0c7a5fab406d27ac6fcb367c98307Test
https://jitc.bmj.com/content/9/5/e002339.fullTest -
5
المؤلفون: Chunyan Lan, Zhimin Liu, Dongqin Zhu, Fan Yang, Minjun He, Hongyu Peng, Chongjie Tong, Xiao-Long Zhang, Xin Huang, Jiani C. Yin, Junli Zhang, Yang Shao
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Time Factors, Pyridines, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Phases of clinical research, Uterine Cervical Neoplasms, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Immunotherapy Biomarkers, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Apatinib, Immune Checkpoint Inhibitors, RC254-282, Cervical cancer, biology, medicine.diagnostic_test, High-Throughput Nucleotide Sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, drug therapy, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Female, immunotherapy, Signal Transduction, Adult, medicine.medical_specialty, Combination therapy, Immunology, Antibodies, Monoclonal, Humanized, Risk Assessment, 03 medical and health sciences, Predictive Value of Tests, Internal medicine, Biopsy, medicine, PTEN, Humans, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Aged, combination, Pharmacology, business.industry, Gene Expression Profiling, Immunotherapy, medicine.disease, 030104 developmental biology, chemistry, genetic markers, biology.protein, business, Transcriptome
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04b4bdd5597fc08e7efbeb45dcf1695Test
https://jitc.bmj.com/content/9/5/e002223.fullTest -
6
المؤلفون: Soudabeh Rad Pour, Xavier Martinez Demorentin, Yago Pico de Coaña, David Gomez-Cabrero, Maria Wolodarski, Johan Hansson, Manjula Thimma, Rolf Kiessling, Jeroen Melief, Jesper Tegnér
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, active, Monocytes, 0302 clinical medicine, Immunology and Allergy, RNA-Seq, Immune Checkpoint Inhibitors, Melanoma, RC254-282, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, medicine.diagnostic_test, CD4-CD8 ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Flow Cytometry, Nivolumab, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, Single-Cell Analysis, Adult, medicine.medical_specialty, Immunology, therapies, investigational, Peripheral blood mononuclear cell, Flow cytometry, 03 medical and health sciences, Predictive Value of Tests, Internal medicine, gene expression profiling, medicine, Calgranulin B, Humans, Aged, Sweden, Pharmacology, business.industry, Monocyte, Immunotherapy, medicine.disease, Blockade, 030104 developmental biology, business, Checkpoint Blockade Immunotherapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dce267ed6b6145ca7733d8384ece8faTest
https://jitc.bmj.com/content/9/5/e002171.fullTest -
7
المؤلفون: Jeffrey R. Infante, Patrick Schöffski, Michael S. Gordon, Alain Ravaud, Manish Agrawal, John Allan Ellerton, Juliane Manitz, Manish R. Patel, Mary Ruisi, Andrea B. Apolo, Matthew H. Taylor, Luc Dirix, Ding Wang, Keun Wook Lee, Raid Aljumaily, Gregory Pennock, Theodore Gourdin, J.L. Gulley
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Immunology, Antibodies, Monoclonal, Humanized, Gastroenterology, B7-H1 Antigen, programmed cell death 1 receptor, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Programmed cell death 1, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Medicine, Humans, Until Disease Progression, Solid tumor, RC254-282, Urothelial carcinoma, Aged, Platinum, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, Second-line therapy, Carcinoma, Transitional Cell, biology, clinical trials as topic, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Toxicity, biology.protein, Molecular Medicine, Female, business, urinary bladder neoplasms, medicine.drug
وصف الملف: Print
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5b9fa96546aac04d870e76ec58182cTest
https://jitc.bmj.com/content/8/2/e001246.fullTest -
8
المؤلفون: Yaping Wu, Brendan D. Curti, Zhaoyu Sun, William L. Redmond, Brady Bernard, Christopher B. Fountain, Peter G. Traber, Takashi Shimada, Yoshinobu Koguchi, Rom Leidner, Eliezer Zomer, Elizabeth Sturgill, George Morris, Venkatesh Rajamanickam, Noriko Iwamoto, Annah S Rolig, Ian Hilgart-Martiszus, J. Rex Horton, Shu Ching Chang, Harold Shlevin
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Immune Checkpoint Inhibitors, T-lymphocytes, RC254-282, Clinical/Translational Cancer Immunotherapy, clinical trials as topic, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Blood Proteins, Middle Aged, Treatment Outcome, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, immunohistochemistry, Molecular Medicine, Pectins, Female, Multiple Myeloma, Adult, medicine.medical_specialty, Galectins, Immunology, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Memory T Cells, Immune system, Internal medicine, medicine, Humans, Aged, Pharmacology, Autoimmune disease, business.industry, Squamous Cell Carcinoma of Head and Neck, Myeloid-Derived Suppressor Cells, Immunotherapy, medicine.disease, Head and neck squamous-cell carcinoma, Blockade, 030104 developmental biology, Myeloid-derived Suppressor Cell, business, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a1c844347afeb00988b18adab8210aeTest
https://jitc.bmj.com/content/9/4/e002371.fullTest -
9
المؤلفون: Yunpeng Yang, Yang Zhang, Hua Bao, Xue Wu, Wanxiangfu Tang, Shaodong Hong, Wenfeng Fang, Ao Wang, Yang Shao, Li Zhang, Yan Huang, Qingguang Lin, Yuxiang Ma, Hongyun Zhao, Xi Chen
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Gene Dosage, Granzymes, Metastasis, 0302 clinical medicine, Immunotherapy Biomarkers, Immunology and Allergy, Immune Checkpoint Inhibitors, RC254-282, Nasopharyngeal Carcinoma, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Female, immunotherapy, Adult, medicine.medical_specialty, DNA Copy Number Variations, Immunology, Antibodies, Monoclonal, Humanized, GZMB, 03 medical and health sciences, Young Adult, Clinical Trials, Phase II as Topic, head and neck neoplasms, Internal medicine, medicine, Biomarkers, Tumor, Humans, Aged, Retrospective Studies, Pharmacology, Chemotherapy, business.industry, Nasopharyngeal Neoplasms, Immunotherapy, medicine.disease, Granzyme B, 030104 developmental biology, Granzyme, Nasopharyngeal carcinoma, Drug Resistance, Neoplasm, tumor biomarkers, biology.protein, business, Granzyme H
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3e933c8331f27c24226e77838695cf3Test
https://jitc.bmj.com/content/9/3/e002014.fullTest -
10
المؤلفون: Hao-Wei Wang, Richard F. Ambinder, Thomas S. Uldrick, Anaida Widell, Ralph Mangusan, Irene Ekwede, Martin A. Cheever, Robert Yarchoan, James L. Gulley, Kathryn Lurain, Ramya Ramaswami, Priscila H. Goncalves, Jomy M. George
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Male, Oncology, Cancer Research, Time Factors, Angiogenesis Inhibitors, HIV Infections, Pembrolizumab, immunomodulation, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, hematologic neoplasms, B-cell lymphoma, Immune Checkpoint Inhibitors, RC254-282, Lymphoma, AIDS-Related, Clinical/Translational Cancer Immunotherapy, Lymphoma, Non-Hodgkin, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, Thalidomide, Disease Progression, Molecular Medicine, Female, immunotherapy, Primary effusion lymphoma, medicine.drug, Adult, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, programmed cell death 1 receptor, Internal medicine, medicine, Humans, Aged, Retrospective Studies, Pharmacology, business.industry, Pomalidomide, medicine.disease, Lymphoma, Non-Hodgkin's lymphoma, business, Diffuse large B-cell lymphoma, Plasmablastic lymphoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f9339bca5148f0d2bc875b304625b2Test
https://jitc.bmj.com/content/9/2/e002097.fullTest